This is a review of development of technology for fractionation of hum
an blood plasma into derivatives for clinical use. Advantages and disa
dvantages of the original cryoethanol method by Cohn and procedures de
rived from this method are compared with the more recent procedures. P
articularly emphasized are problems related to contamination of plasma
derivatives with pathogenic viruses.